Strong economic growth and the prospect of declining interest rates continue to support gains in global equities.

A weekly summary of insider trading highlighting a few notable buying and selling by investors, directors and executives. The ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

Despite losses in the Indian stock market, 10 BSE 500 stocks surged 15-29% this year, outperforming gold. Factors like FPI ...

MongoDB shows bullish technicals but faces weakened fundamentals with declining growth. See why now may be the time to sell ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Buy, Sell, or Hold? For risk-tolerant investors, Kinross Gold is a buy on the dip. For others, hold and watch the gold price ...

As automakers consolidate purchases with fewer suppliers, large vendors such as Magna are in the best position to gain share because they can offer a wide range of parts, modules, and complete systems ...

That limits the ability of producers to grow, although low-cost operators like Antero can still theoretically take share. However, Antero has been more interested in merely maintaining its output and ...

Mark Sabag, Executive Vice President of International Markets Commercial at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), recently sold a substantial block of the company's ordinary shares. The ...

EST 60 Degrees Pharmaceuticals (SXTP) files to sell 3.74M shares of common stock for holderMaximize Your Portfolio with Data Driven ...

Closing of the Shares for Debt Arrangement is anticipated to be on or about February 24, 2025 in accordance with the policies of the Canadian Securities Exchange.